Farsiu, Sina
- Duke University · Ophthalmology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #5,467
- Program Leader
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Ophthalmology
NIH Funding · FY2023
Linked Award Amount
$1.6M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#5,467
By linked amount among FY2023 PIs
Earliest Year Loaded
2022
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Farsiu, Sina as a PI. Multi-PI records show the full award amount for context.
- 5U01EY034687-02U01Contact PIBlink, Lacrimation, and Nociception: Precision Mapping and Integrated Atlas Generation of Corneal Trigeminal AfferentsDuke University · Ophthalmology (NIH department code)$1.3Maward amount
- 5UG1EY033287-02UG1Contact PINAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial with retinitis pigmentosa: OCT Reading CenterDuke University · Ophthalmology (NIH department code)$255.3Kaward amount
Award organization
Organizations that administered FY2023 awards listing Farsiu, Sina as a PI.
FY2023 award administered by Duke University (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH AwardDuke University
- 2022$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #5294
- 2023$2M Cumulative Funding